Ventures in Residence

GRO Biosciences

Therapeutic proteins are often made in expensive systems because they have chemical bonds that do not form in microbes. These bonds can also break in blood plasma, causing poor serum half-life. Using our microbes with an expanded genetic code, GRObio makes therapeutic proteins with new stabilizing bonds to enable inexpensive microbial fermentation, fast production times, and long serum half-life.

Schools
  • Harvard Medical School
  • Wyss Institute
Semesters
  • Fall 2016
Venture Status
  • Full-Time Postdoc
Industries
  • Biologics/Therapeutics